THE EFFECT OF MICROBIAL CONTAMINANTS ON THE IDENTITY AND CONTENT OF ACTIVE INGREDIENTS IN DRUGS
- Authors: Gunar O.V.1, Roshchina M.V.1, Buylova I.A.1, Sakhno N.G.1, Bulgakova G.M.1
-
Affiliations:
- Research Center for Examination of Medical Products, Ministry of Health of the Russian Federation
- Issue: Vol 68, No 7 (2019)
- Pages: 5-10
- Section: Articles
- URL: https://journals.eco-vector.com/0367-3014/article/view/113185
- DOI: https://doi.org/10.29296/25419218-2019-07-01
- ID: 113185
Cite item
Abstract
Full Text
About the authors
Olga Viktorovna Gunar
Research Center for Examination of Medical Products, Ministry of Health of the Russian Federation
Email: gunar@expmed.ru
Head of Laboratory of Microbiology, Doctor of Pharmaceutical Sciences 8, Petrovsky Boulevard, Build. 2, Moscow 127051, Russian Federation
Marina Vladimirovna Roshchina
Research Center for Examination of Medical Products, Ministry of Health of the Russian Federation
Email: roshchina@mail.ru
1-st category Expert of Laboratory of Microbiology 8, Petrovsky Boulevard, Build. 2, Moscow 127051, Russian Federation
Irina Aleksandrovna Buylova
Research Center for Examination of Medical Products, Ministry of Health of the Russian Federation
Email: schulya090481@mail.ru
Leading Expert of Laboratory of Microbiology,PhD 8, Petrovsky Boulevard, Build. 2, Moscow 127051, Russian Federation
Nadezhda Gennad'evna Sakhno
Research Center for Examination of Medical Products, Ministry of Health of the Russian Federation
Email: nadine87@inbox.ru
Chief expert of Laboratory of Microbiology,PhD 8, Petrovsky Boulevard, Build. 2, Moscow 127051, Russian Federation
Galina Mikhaylovna Bulgakova
Research Center for Examination of Medical Products, Ministry of Health of the Russian Federation
Email: bulgakova@expmed.ru
Leading Expert of Laboratory of Microbiology 8, Petrovsky Boulevard, Build. 2, Moscow 127051, Russian Federation
References
- Kailings L. Secretariat of the European Free Trade Association, 1973; 17-23.
- Гаврилов А.С. Фармацевтическая технология. Изготовление лекарственных средств. М.: ГЭОТАР-Медиа, 2010;624.
- Гунар О.В., Сахно Н.Г., Рощина М.В., Григорьева В.Э., Меркулов В.А. Оценка микробиологической чистоты нестерильных лекарственных средств и видовая оценка микроорганизмов-контаминантов. Ведомости Научного центра экспертизы средств медицинского применения, 2014;4: 7-11.
- Федотов А.Е. Производство стерильных лекарственных средств. М.: Асинком, 2012; 400.
- Sandle T. A review of cleanroom microflora: types, trends, and patterns. PDA Journal of pharmaceutical science and technology, 2011; 65: 392-403.
- Jimenez L., Kulko E., Barron E. et al. Burkholderia cepacia: A problem that does not go away! EC Microbiology, 2015; 2 (1): 205-10.
- Singhal T., Shah S., Naik R. Outbreak of Burkholderia cepacia complex bacteremia in a chemotherapy day care unit due to intrinsic contamination of an antiemetic drug. Indian journal of medical microbiology, 2015; 33 (1): 117-9.
- Kim J.M., Ahn Y., LiPuma J.J. et al. Survival and susceptibility of Burkholderia cepacia complex in chlorhexidine gluconate and benzalkonium chloride. Journal of industrial microbiology and biotechnology, 2015; 42 (6): 905-13.
- Zani F., Minutello A., Maggi L. et al. Evaluation of preservative effectiveness in pharmaceutical products: the use of a wild strain of Pseudomonas cepacia. Journal of applied microbiology, 1997; 83 (3):322-6.
- Rose H., Baldwin A., Dowson C.G. et al. Biocide susceptibility of the Burkholderia cepacia complex. Journal of antimicrobial chemotherapy, 2009; 63 (3):502-10.
- Torbeck L., Raccasi D., Guilfoyle D.E. et al. Burkholderia cepacia, the decision is overdue. PDA journal of pharmaceutical sciences and technology, 2011; 65: 535-43.
- Sutton S., Jimenez L. A Review of Reported Recalls Involving Microbiological Control 2004-2011 with Emphasis on FDA Considerations of «Objectionable Organisms».American pharmaceutical review, 2006; 9: 62-9.
- Jimenez L. Microbial diversity in pharmaceutical product recalls and environments. PDA Journal of Pharmaceutical Science and Technology, 2007; 61 (5):383-99.
- Vijayakumar R., Sandle T., Manoharan C. A review of fungal contamination in pharmaceutical products and phenotypic identification of contaminants by conventional methods. European journal of parenteral and pharmaceutical sciences, 2012; 17 (1): 4-19.
- Lopolito P., Bartnett C., Polarine J. Control strategies for fungal contamination in clean rooms. Controlled environments, 2007; 372: 1-5.